NAYAR RAHUL (Chief Executive Officer) purchased 19.6% of their position (310K shares) of REVIVA PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market purchase worth $3.10M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/24/2018ACC: 0001144204-18-046300
DirectorOfficer10% Owner· Chief Executive Officer
Since Aug 2018
+310K
Net shares
Net buyer
$3.10M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
310K acquired
Non-Derivative Transactions1
Ordinary Shares
Indirect
Shares
+310K
Price / share
$10.00
Trade value
$3.10M
% of position
19.6%
8/23/2018
1.58M→1.89M
Total
Net shares
+310K
Net value
$3.10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 8/23/2018 | P · Purchase | +310K | $10.00 | $3.10M | 19.6% | 1.58M | 1.89M |
| Total | +310K | $3.10M | ||||||
Derivative Transactions0
No derivative transactions reported